Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Crinetics Pharmaceuticals Inc Share Price

CRNX

NSQ

$44.08

-$3.53

(-7.41%)

Industry: Biotechnology Sector: Health Care

Crinetics Pharmaceuticals Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Crinetics Pharmaceuticals Inc Share Price Chart

Crinetics Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$4.88B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

915.55K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.19

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$24.1 L

$57.99 H

$44.08

About Crinetics Pharmaceuticals Inc, Common Stock

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in a Phase 3 clinical trial for the treatment of acromegaly and carcinoid syndrome associated with neuroendocrine tumors. It is also developing Atumelnant, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and cushing's disease; and CRN09682, a nonpeptide drug conjugate for SST2 positive solid tumors. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease; SST3 Agonist program for the treatment for autosomal dominant polycystic kidney disease; and Radionetics for multiple solid-tumors, as well as Oral GLP-1 and Oral GIP nonpeptides for the treatment of obesity. The company has an agreement with Sanwa Kagaku Kenkyusho Co., Ltd to develop and commercialize Paltusotine in Japan, and Cellular Longevity, Inc. to develop and commercialize CRN01941, a somatostatin receptor type 2 agonist. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California. more

Industry: BiotechnologySector: Health Care

Crinetics Pharmaceuticals Inc Stock Returns

Time Frame	CRNX	Sector	S&P500
1-Week Return	-1.59%	0.91%	2.13%
1-Month Return	-20.36%	-0.72%	-0.47%
3-Month Return	2.94%	2.24%	1.29%
6-Month Return	54.78%	19.1%	7.71%
1-Year Return	25.19%	7.15%	14.7%
3-Year Return	119.85%	16.96%	67.75%
5-Year Return	171.93%	33.23%	76.25%
10-Year Return	79.84%	142.74%	271.83%

Time Frame	CRNX	Sector	S&P500
1-Week Return	-56.64%	60.38%	200.11%
1-Month Return	-93.73%	-8.42%	-5.57%
3-Month Return	12.47%	9.40%	5.34%
6-Month Return	142.49%	42.54%	16.25%
1-Year Return	25.19%	7.15%	14.70%
3-Year Return	30.03%	5.36%	18.82%
5-Year Return	22.15%	5.91%	12.00%
10-Year Return	6.04%	9.27%	14.03%

Crinetics Pharmaceuticals Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	71.00K	1.08M	4.74M	4.01M	1.04M	[{"date":"2020-12-31","value":1.5,"profit":true},{"date":"2021-12-31","value":22.76,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":84.72,"profit":true},{"date":"2024-12-31","value":21.93,"profit":true}]
Cost of Revenue	57.00M	1.26M	1.39M	1.10M	2.79M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":2.21,"profit":true},{"date":"2022-12-31","value":2.44,"profit":true},{"date":"2023-12-31","value":1.93,"profit":true},{"date":"2024-12-31","value":4.89,"profit":true}]
Gross Profit	71.00K	1.08M	4.74M	4.01M	1.04M	[{"date":"2020-12-31","value":1.5,"profit":true},{"date":"2021-12-31","value":22.76,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":84.72,"profit":true},{"date":"2024-12-31","value":21.93,"profit":true}]
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Operating Expenses	74.95M	108.78M	172.62M	226.62M	339.89M	[{"date":"2020-12-31","value":22.05,"profit":true},{"date":"2021-12-31","value":32,"profit":true},{"date":"2022-12-31","value":50.79,"profit":true},{"date":"2023-12-31","value":66.67,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(74.95M)	(107.70M)	(167.88M)	(222.61M)	(338.85M)	[{"date":"2020-12-31","value":-7495300000,"profit":false},{"date":"2021-12-31","value":-10770200000,"profit":false},{"date":"2022-12-31","value":-16788200000,"profit":false},{"date":"2023-12-31","value":-22260800000,"profit":false},{"date":"2024-12-31","value":-33885400000,"profit":false}]
Total Non-Operating Income/Expense	2.13M	218.00K	8.28M	21.52M	81.88M	[{"date":"2020-12-31","value":2.6,"profit":true},{"date":"2021-12-31","value":0.27,"profit":true},{"date":"2022-12-31","value":10.11,"profit":true},{"date":"2023-12-31","value":26.28,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	(73.81M)	(107.64M)	(163.92M)	(214.53M)	(298.41M)	[{"date":"2020-12-31","value":-7381200000,"profit":false},{"date":"2021-12-31","value":-10764100000,"profit":false},{"date":"2022-12-31","value":-16391800000,"profit":false},{"date":"2023-12-31","value":-21452900000,"profit":false},{"date":"2024-12-31","value":-29840800000,"profit":false}]
Income Taxes	(948.00K)	(922.00K)	(3.96M)	930.11K	-	[{"date":"2020-12-31","value":-101.92,"profit":false},{"date":"2021-12-31","value":-99.13,"profit":false},{"date":"2022-12-31","value":-426.19,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	(72.86M)	(106.72M)	(159.95M)	(215.46M)	-	[{"date":"2020-12-31","value":-7286400000,"profit":false},{"date":"2021-12-31","value":-10671900000,"profit":false},{"date":"2022-12-31","value":-15995400000,"profit":false},{"date":"2023-12-31","value":-21545910500,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(73.81M)	(107.64M)	(163.92M)	(214.53M)	(298.41M)	[{"date":"2020-12-31","value":-7381200000,"profit":false},{"date":"2021-12-31","value":-10764100000,"profit":false},{"date":"2022-12-31","value":-16391800000,"profit":false},{"date":"2023-12-31","value":-21452900000,"profit":false},{"date":"2024-12-31","value":-29840800000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(72.86M)	(106.72M)	(159.95M)	(214.53M)	(298.41M)	[{"date":"2020-12-31","value":-7286400000,"profit":false},{"date":"2021-12-31","value":-10671900000,"profit":false},{"date":"2022-12-31","value":-15995400000,"profit":false},{"date":"2023-12-31","value":-21452900000,"profit":false},{"date":"2024-12-31","value":-29840800000,"profit":false}]

EPS (Diluted)	(2.46)	(2.80)	(3.14)	(3.70)	(3.71)	[{"date":"2020-12-31","value":-246,"profit":false},{"date":"2021-12-31","value":-280,"profit":false},{"date":"2022-12-31","value":-314,"profit":false},{"date":"2023-12-31","value":-370,"profit":false},{"date":"2024-12-31","value":-371,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	1418.31%	339.42%	(15.28%)	(74.11%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":23.93,"profit":true},{"date":"2023-12-31","value":-1.08,"profit":false},{"date":"2024-12-31","value":-5.23,"profit":false}]
Cost of Revenue	-	(97.79%)	10.06%	(20.95%)	153.64%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-63.64,"profit":false},{"date":"2022-12-31","value":6.55,"profit":true},{"date":"2023-12-31","value":-13.64,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	-	1418.31%	339.42%	(15.28%)	(74.11%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":23.93,"profit":true},{"date":"2023-12-31","value":-1.08,"profit":false},{"date":"2024-12-31","value":-5.23,"profit":false}]
Gross Margin	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	45.13%	58.69%	31.28%	49.98%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":76.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":53.31,"profit":true},{"date":"2024-12-31","value":85.17,"profit":true}]
Operating Income	-	43.69%	55.88%	32.60%	52.22%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":78.2,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":58.34,"profit":true},{"date":"2024-12-31","value":93.46,"profit":true}]
Total Non-Operating Income/Expense	-	(89.77%)	3698.62%	159.81%	280.58%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-2.43,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":4.32,"profit":true},{"date":"2024-12-31","value":7.59,"profit":true}]
Pre-Tax Income	-	45.83%	52.28%	30.88%	39.10%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":87.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":59.06,"profit":true},{"date":"2024-12-31","value":74.78,"profit":true}]
Income Taxes	-	(2.74%)	329.93%	(123.46%)	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-0.83,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-37.42,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	46.46%	49.88%	34.70%	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":93.14,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":69.56,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	45.83%	52.28%	30.88%	39.10%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":87.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":59.06,"profit":true},{"date":"2024-12-31","value":74.78,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	46.46%	49.88%	34.12%	39.10%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":93.14,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":68.4,"profit":true},{"date":"2024-12-31","value":78.38,"profit":true}]

EPS (Diluted)	-	13.82%	12.14%	17.83%	0.27%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":77.5,"profit":true},{"date":"2022-12-31","value":68.09,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":1.52,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	-	361.00K	1.03M	143.00K	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":35.01,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":13.87,"profit":true}]
Cost of Revenue	770.00K	1.23M	-	959.00K	90.46M	[{"date":"2024-09-30","value":0.85,"profit":true},{"date":"2024-12-31","value":1.36,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":1.06,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	(770.00K)	188.00K	361.00K	1.03M	143.00K	[{"date":"2024-09-30","value":-74.68,"profit":false},{"date":"2024-12-31","value":18.23,"profit":true},{"date":"2025-03-31","value":35.01,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":13.87,"profit":true}]
Gross Margin	-	-	100.00%	100.00%	100.00%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Operating Expenses	87.80M	94.75M	111.77M	130.14M	142.73M	[{"date":"2024-09-30","value":61.51,"profit":true},{"date":"2024-12-31","value":66.38,"profit":true},{"date":"2025-03-31","value":78.31,"profit":true},{"date":"2025-06-30","value":91.18,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Operating Income	(87.80M)	(94.75M)	(111.41M)	(129.11M)	(142.59M)	[{"date":"2024-09-30","value":-8779700000,"profit":false},{"date":"2024-12-31","value":-9474500000,"profit":false},{"date":"2025-03-31","value":-11140500000,"profit":false},{"date":"2025-06-30","value":-12911200000,"profit":false},{"date":"2025-09-30","value":-14258600000,"profit":false}]
Total Non-Operating Income/Expense	21.98M	28.52M	29.46M	26.93M	25.04M	[{"date":"2024-09-30","value":74.58,"profit":true},{"date":"2024-12-31","value":96.79,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":91.4,"profit":true},{"date":"2025-09-30","value":84.98,"profit":true}]
Pre-Tax Income	(76.83M)	(80.59M)	(96.77M)	(115.64M)	(130.09M)	[{"date":"2024-09-30","value":-7682800000,"profit":false},{"date":"2024-12-31","value":-8059500000,"profit":false},{"date":"2025-03-31","value":-9677400000,"profit":false},{"date":"2025-06-30","value":-11563700000,"profit":false},{"date":"2025-09-30","value":-13009100000,"profit":false}]
Income Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(76.83M)	(80.59M)	(96.77M)	(115.64M)	(130.09M)	[{"date":"2024-09-30","value":-7682800000,"profit":false},{"date":"2024-12-31","value":-8059500000,"profit":false},{"date":"2025-03-31","value":-9677400000,"profit":false},{"date":"2025-06-30","value":-11563700000,"profit":false},{"date":"2025-09-30","value":-13009100000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(76.83M)	(80.59M)	(96.77M)	(115.64M)	(130.09M)	[{"date":"2024-09-30","value":-7682800000,"profit":false},{"date":"2024-12-31","value":-8059500000,"profit":false},{"date":"2025-03-31","value":-9677400000,"profit":false},{"date":"2025-06-30","value":-11563700000,"profit":false},{"date":"2025-09-30","value":-13009100000,"profit":false}]

EPS (Diluted)	(0.96)	(0.88)	(1.04)	(1.23)	(1.38)	[{"date":"2024-09-30","value":-96,"profit":false},{"date":"2024-12-31","value":-88,"profit":false},{"date":"2025-03-31","value":-104,"profit":false},{"date":"2025-06-30","value":-123,"profit":false},{"date":"2025-09-30","value":-138,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	-	-	185.60%	(86.13%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-46.41,"profit":false}]
Cost of Revenue	-	59.35%	-	-	9333.16%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":0.64,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	-	(124.42%)	92.02%	185.60%	(86.13%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-67.04,"profit":false},{"date":"2025-03-31","value":49.58,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-46.41,"profit":false}]
Gross Margin	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	-	7.91%	17.97%	16.44%	9.67%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":44.05,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":91.52,"profit":true},{"date":"2025-09-30","value":53.83,"profit":true}]
Operating Income	-	7.91%	17.58%	15.89%	10.44%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":45.01,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":90.39,"profit":true},{"date":"2025-09-30","value":59.35,"profit":true}]
Total Non-Operating Income/Expense	-	29.77%	3.32%	(8.60%)	(7.02%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":11.15,"profit":true},{"date":"2025-06-30","value":-28.9,"profit":false},{"date":"2025-09-30","value":-23.58,"profit":false}]
Pre-Tax Income	-	4.90%	20.07%	19.49%	12.50%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":24.42,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":97.1,"profit":true},{"date":"2025-09-30","value":62.27,"profit":true}]
Income Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	4.90%	20.07%	19.49%	12.50%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":24.42,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":97.1,"profit":true},{"date":"2025-09-30","value":62.27,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	4.90%	20.07%	19.49%	12.50%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":24.42,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":97.1,"profit":true},{"date":"2025-09-30","value":62.27,"profit":true}]

EPS (Diluted)	-	(8.33%)	18.18%	18.27%	12.20%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-45.61,"profit":false},{"date":"2025-03-31","value":99.52,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":66.75,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	177.49M	344.72M	345.18M	574.15M	1.38B	[{"date":"2020-12-31","value":12.9,"profit":true},{"date":"2021-12-31","value":25.06,"profit":true},{"date":"2022-12-31","value":25.1,"profit":true},{"date":"2023-12-31","value":41.74,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	5.95M	6.29M	6.99M	61.20M	59.20M	[{"date":"2020-12-31","value":9.73,"profit":true},{"date":"2021-12-31","value":10.29,"profit":true},{"date":"2022-12-31","value":11.42,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.74,"profit":true}]
Total Assets	183.44M	351.01M	352.18M	635.35M	1.43B	[{"date":"2020-12-31","value":12.79,"profit":true},{"date":"2021-12-31","value":24.47,"profit":true},{"date":"2022-12-31","value":24.55,"profit":true},{"date":"2023-12-31","value":44.29,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	10.49M	15.99M	27.72M	43.94M	59.68M	[{"date":"2020-12-31","value":17.57,"profit":true},{"date":"2021-12-31","value":26.8,"profit":true},{"date":"2022-12-31","value":46.45,"profit":true},{"date":"2023-12-31","value":73.62,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	4.04M	3.08M	8.13M	52.30M	50.10M	[{"date":"2020-12-31","value":7.72,"profit":true},{"date":"2021-12-31","value":5.88,"profit":true},{"date":"2022-12-31","value":15.53,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":95.79,"profit":true}]
Total Liabilities	14.53M	19.07M	35.85M	96.25M	109.79M	[{"date":"2020-12-31","value":13.23,"profit":true},{"date":"2021-12-31","value":17.37,"profit":true},{"date":"2022-12-31","value":32.65,"profit":true},{"date":"2023-12-31","value":87.67,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	336.51M	607.58M	759.43M	1.19B	2.28B	[{"date":"2020-12-31","value":14.79,"profit":true},{"date":"2021-12-31","value":26.7,"profit":true},{"date":"2022-12-31","value":33.37,"profit":true},{"date":"2023-12-31","value":52.37,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(167.61M)	(275.25M)	(439.17M)	(653.70M)	(952.11M)	[{"date":"2020-12-31","value":-16761400000,"profit":false},{"date":"2021-12-31","value":-27525500000,"profit":false},{"date":"2022-12-31","value":-43917300000,"profit":false},{"date":"2023-12-31","value":-65370200000,"profit":false},{"date":"2024-12-31","value":-95211000000,"profit":false}]
Other Stockholders' Equity	(336.53M)	(607.20M)	(755.50M)	-	-	[{"date":"2020-12-31","value":-33653300000,"profit":false},{"date":"2021-12-31","value":-60719900000,"profit":false},{"date":"2022-12-31","value":-75550100000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	168.92M	331.94M	316.33M	539.11M	1.32B	[{"date":"2020-12-31","value":12.75,"profit":true},{"date":"2021-12-31","value":25.06,"profit":true},{"date":"2022-12-31","value":23.88,"profit":true},{"date":"2023-12-31","value":40.69,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	183.44M	351.01M	352.18M	635.35M	1.43B	[{"date":"2020-12-31","value":12.79,"profit":true},{"date":"2021-12-31","value":24.47,"profit":true},{"date":"2022-12-31","value":24.55,"profit":true},{"date":"2023-12-31","value":44.29,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	94.22%	0.13%	66.33%	139.55%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":67.51,"profit":true},{"date":"2022-12-31","value":0.1,"profit":true},{"date":"2023-12-31","value":47.53,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	-	5.75%	11.07%	775.29%	(3.26%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.74,"profit":true},{"date":"2022-12-31","value":1.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-0.42,"profit":false}]
Total Assets	-	91.35%	0.33%	80.41%	125.79%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":72.62,"profit":true},{"date":"2022-12-31","value":0.26,"profit":true},{"date":"2023-12-31","value":63.92,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	52.49%	73.32%	58.50%	35.82%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":71.59,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.79,"profit":true},{"date":"2024-12-31","value":48.86,"profit":true}]
Non-current Liabilities	-	(23.80%)	164.14%	543.75%	(4.21%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-4.38,"profit":false},{"date":"2022-12-31","value":30.19,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-0.77,"profit":false}]
Total Liabilities	-	31.29%	87.97%	168.49%	14.07%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":18.57,"profit":true},{"date":"2022-12-31","value":52.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":8.35,"profit":true}]

Total Shareholders' equity
Common Stock	-	80.55%	24.99%	56.94%	90.96%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":88.56,"profit":true},{"date":"2022-12-31","value":27.48,"profit":true},{"date":"2023-12-31","value":62.59,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	-	64.22%	59.55%	48.85%	45.65%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":92.73,"profit":true},{"date":"2023-12-31","value":76.06,"profit":true},{"date":"2024-12-31","value":71.08,"profit":true}]
Other Stockholders' Equity	-	80.43%	24.42%	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":30.37,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	96.51%	(4.70%)	70.43%	145.74%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":66.22,"profit":true},{"date":"2022-12-31","value":-3.23,"profit":false},{"date":"2023-12-31","value":48.32,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	91.35%	0.33%	80.41%	125.79%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":72.62,"profit":true},{"date":"2022-12-31","value":0.26,"profit":true},{"date":"2023-12-31","value":63.92,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	877.59M	1.38B	1.29B	1.22B	1.12B	[{"date":"2024-09-30","value":63.81,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":93.87,"profit":true},{"date":"2025-06-30","value":88.5,"profit":true},{"date":"2025-09-30","value":81.52,"profit":true}]
Non-current Assets	59.79M	59.20M	70.27M	72.31M	74.76M	[{"date":"2024-09-30","value":79.98,"profit":true},{"date":"2024-12-31","value":79.2,"profit":true},{"date":"2025-03-31","value":94,"profit":true},{"date":"2025-06-30","value":96.73,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	937.37M	1.43B	1.36B	1.29B	1.20B	[{"date":"2024-09-30","value":65.34,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":94.89,"profit":true},{"date":"2025-06-30","value":89.89,"profit":true},{"date":"2025-09-30","value":83.37,"profit":true}]

Total Liabilities
Current Liabilities	53.56M	59.68M	57.31M	68.40M	74.16M	[{"date":"2024-09-30","value":72.23,"profit":true},{"date":"2024-12-31","value":80.49,"profit":true},{"date":"2025-03-31","value":77.29,"profit":true},{"date":"2025-06-30","value":92.23,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	50.83M	50.10M	50.02M	49.65M	49.71M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":98.57,"profit":true},{"date":"2025-03-31","value":98.39,"profit":true},{"date":"2025-06-30","value":97.68,"profit":true},{"date":"2025-09-30","value":97.79,"profit":true}]
Total Liabilities	104.39M	109.79M	107.33M	118.05M	123.86M	[{"date":"2024-09-30","value":84.28,"profit":true},{"date":"2024-12-31","value":88.64,"profit":true},{"date":"2025-03-31","value":86.65,"profit":true},{"date":"2025-06-30","value":95.31,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	1.70B	2.28B	2.30B	2.33B	2.36B	[{"date":"2024-09-30","value":71.99,"profit":true},{"date":"2024-12-31","value":96.25,"profit":true},{"date":"2025-03-31","value":97.3,"profit":true},{"date":"2025-06-30","value":98.72,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(871.51M)	(952.11M)	(1.05B)	(1.16B)	(1.29B)	[{"date":"2024-09-30","value":-87151500000,"profit":false},{"date":"2024-12-31","value":-95211000000,"profit":false},{"date":"2025-03-31","value":-104888400000,"profit":false},{"date":"2025-06-30","value":-116452100000,"profit":false},{"date":"2025-09-30","value":-129461200000,"profit":false}]
Other Stockholders' Equity	-	-	-	(112.00K)	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":-11200000,"profit":false},{"date":"2025-09-30","value":"-","profit":true}]
Total Shareholders' equity	832.98M	1.32B	1.25B	1.17B	1.07B	[{"date":"2024-09-30","value":62.88,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":94.66,"profit":true},{"date":"2025-06-30","value":88.43,"profit":true},{"date":"2025-09-30","value":80.93,"profit":true}]

Total Liabilities & Shareholders Equity	937.37M	1.43B	1.36B	1.29B	1.20B	[{"date":"2024-09-30","value":65.34,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":94.89,"profit":true},{"date":"2025-06-30","value":89.89,"profit":true},{"date":"2025-09-30","value":83.37,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	56.72%	(6.13%)	(5.72%)	(7.89%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-10.81,"profit":false},{"date":"2025-06-30","value":-10.08,"profit":false},{"date":"2025-09-30","value":-13.9,"profit":false}]
Non-current Assets	-	(0.98%)	18.69%	2.90%	3.38%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-5.22,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":15.51,"profit":true},{"date":"2025-09-30","value":18.09,"profit":true}]
Total Assets	-	53.04%	(5.11%)	(5.27%)	(7.25%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-9.63,"profit":false},{"date":"2025-06-30","value":-9.94,"profit":false},{"date":"2025-09-30","value":-13.68,"profit":false}]

Total Liabilities
Current Liabilities	-	11.43%	(3.98%)	19.34%	8.42%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":59.09,"profit":true},{"date":"2025-03-31","value":-20.56,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":43.53,"profit":true}]
Non-current Liabilities	-	(1.43%)	(0.17%)	(0.73%)	0.11%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1294.69,"profit":false},{"date":"2025-03-31","value":-156.76,"profit":false},{"date":"2025-06-30","value":-657,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	-	5.17%	(2.24%)	9.99%	4.93%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":51.72,"profit":true},{"date":"2025-03-31","value":-22.43,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":49.3,"profit":true}]

Total Shareholders' equity
Common Stock	-	33.69%	1.10%	1.46%	1.29%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":3.25,"profit":true},{"date":"2025-06-30","value":4.34,"profit":true},{"date":"2025-09-30","value":3.84,"profit":true}]
Retained Earnings	-	9.25%	10.16%	11.02%	11.17%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":82.78,"profit":true},{"date":"2025-03-31","value":90.99,"profit":true},{"date":"2025-06-30","value":98.69,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Total Shareholders' equity	-	59.04%	(5.34%)	(6.58%)	(8.48%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-9.05,"profit":false},{"date":"2025-06-30","value":-11.14,"profit":false},{"date":"2025-09-30","value":-14.36,"profit":false}]

Total Liabilities & Shareholders Equity	-	53.04%	(5.11%)	(5.27%)	(7.25%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-9.63,"profit":false},{"date":"2025-06-30","value":-9.94,"profit":false},{"date":"2025-09-30","value":-13.68,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(62.03M)	(88.59M)	(115.20M)	(166.31M)	(225.97M)	[{"date":"2020-12-31","value":-6202700000,"profit":false},{"date":"2021-12-31","value":-8858800000,"profit":false},{"date":"2022-12-31","value":-11520500000,"profit":false},{"date":"2023-12-31","value":-16630700000,"profit":false},{"date":"2024-12-31","value":-22597000000,"profit":false}]

Investing Activities
Net Investing Cash Flow	217.00K	(56.48M)	(173.98M)	(200.41M)	(574.82M)	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-26029.03,"profit":false},{"date":"2022-12-31","value":-80175.12,"profit":false},{"date":"2023-12-31","value":-92356.22,"profit":false},{"date":"2024-12-31","value":-264892.63,"profit":false}]

Financing Activities
Net Financing Cash Flow	114.57M	252.68M	121.96M	388.94M	1.01B	[{"date":"2020-12-31","value":11.34,"profit":true},{"date":"2021-12-31","value":25.01,"profit":true},{"date":"2022-12-31","value":12.07,"profit":true},{"date":"2023-12-31","value":38.49,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	52.76M	107.61M	(167.22M)	22.22M	209.65M	[{"date":"2020-12-31","value":25.17,"profit":true},{"date":"2021-12-31","value":51.33,"profit":true},{"date":"2022-12-31","value":-79.76,"profit":false},{"date":"2023-12-31","value":10.6,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(62.21M)	(89.02M)	(116.86M)	(171.00M)	(229.81M)	[{"date":"2020-12-31","value":-6221300000,"profit":false},{"date":"2021-12-31","value":-8902400000,"profit":false},{"date":"2022-12-31","value":-11686100000,"profit":false},{"date":"2023-12-31","value":-17099500000,"profit":false},{"date":"2024-12-31","value":-22981400000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	42.82%	30.05%	44.36%	35.88%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":96.54,"profit":true},{"date":"2022-12-31","value":67.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":80.88,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(26129.03%)	208.02%	15.19%	186.82%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-12560.71,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":7.3,"profit":true},{"date":"2024-12-31","value":89.81,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	120.54%	(51.73%)	218.90%	159.79%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":55.07,"profit":true},{"date":"2022-12-31","value":-23.63,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":73,"profit":true}]

Net Change in Cash	-	103.95%	(255.40%)	(113.29%)	843.34%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":12.33,"profit":true},{"date":"2022-12-31","value":-30.28,"profit":false},{"date":"2023-12-31","value":-13.43,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	43.10%	31.27%	46.32%	34.40%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":93.03,"profit":true},{"date":"2022-12-31","value":67.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":74.26,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(60.80M)	(64.67M)	(88.45M)	(85.85M)	(110.72M)	[{"date":"2024-09-30","value":-6079600000,"profit":false},{"date":"2024-12-31","value":-6467400000,"profit":false},{"date":"2025-03-31","value":-8845200000,"profit":false},{"date":"2025-06-30","value":-8585100000,"profit":false},{"date":"2025-09-30","value":-11071800000,"profit":false}]

Investing Activities
Net Investing Cash Flow	20.60M	(542.09M)	(85.96M)	37.95M	164.81M	[{"date":"2024-09-30","value":12.5,"profit":true},{"date":"2024-12-31","value":-328.92,"profit":false},{"date":"2025-03-31","value":-52.16,"profit":false},{"date":"2025-06-30","value":23.03,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	55.30M	554.04M	4.44M	7.05M	3.08M	[{"date":"2024-09-30","value":9.98,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":0.8,"profit":true},{"date":"2025-06-30","value":1.27,"profit":true},{"date":"2025-09-30","value":0.56,"profit":true}]

Net Change in Cash	15.11M	(52.72M)	(169.98M)	(40.84M)	57.17M	[{"date":"2024-09-30","value":26.42,"profit":true},{"date":"2024-12-31","value":-92.22,"profit":false},{"date":"2025-03-31","value":-297.29,"profit":false},{"date":"2025-06-30","value":-71.44,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(61.32M)	(65.70M)	(89.69M)	(89.05M)	(111.58M)	[{"date":"2024-09-30","value":-6132400000,"profit":false},{"date":"2024-12-31","value":-6570300000,"profit":false},{"date":"2025-03-31","value":-8969100000,"profit":false},{"date":"2025-06-30","value":-8905300000,"profit":false},{"date":"2025-09-30","value":-11158100000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	6.38%	36.77%	(2.94%)	28.97%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":17.35,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-8,"profit":false},{"date":"2025-09-30","value":78.78,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(2731.11%)	(84.14%)	(144.15%)	334.24%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-817.1,"profit":false},{"date":"2025-03-31","value":-25.17,"profit":false},{"date":"2025-06-30","value":-43.13,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	901.88%	(99.20%)	59.00%	(56.29%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-11,"profit":false},{"date":"2025-06-30","value":6.54,"profit":true},{"date":"2025-09-30","value":-6.24,"profit":false}]

Net Change in Cash	-	(449.00%)	222.39%	(75.97%)	(239.99%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-201.9,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-34.16,"profit":false},{"date":"2025-09-30","value":-107.91,"profit":false}]

Free Cash Flow
Free Cash Flow	-	7.14%	36.51%	(0.71%)	25.30%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":19.56,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-1.95,"profit":false},{"date":"2025-09-30","value":69.29,"profit":true}]

Crinetics Pharmaceuticals Inc Ratios

Crinetics Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	CRNX
Cash Ratio	14.73
Current Ratio	15.12

Crinetics Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	CRNX
ROA (LTM)	-28.00%
ROE (LTM)	-44.42%

Crinetics Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	CRNX
Debt Ratio Lower is generally better. Negative is bad.	0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.90

Crinetics Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	CRNX
Trailing PE	NM
Forward PE	NM
P/S (TTM)	3179.54
P/B	4.55
Price/FCF	NM
EV/R	2497.29
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Crinetics Pharmaceuticals Inc share price today?

Crinetics Pharmaceuticals Inc (CRNX) share price today is $44.08

Can Indians buy Crinetics Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Crinetics Pharmaceuticals Inc (CRNX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CRNX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Crinetics Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Crinetics Pharmaceuticals Inc (CRNX) via the Vested app. You can start investing in Crinetics Pharmaceuticals Inc (CRNX) with a minimum investment of $1.

How to invest in Crinetics Pharmaceuticals Inc shares from India?

You can invest in shares of Crinetics Pharmaceuticals Inc (CRNX) via Vested in three simple steps:

Click on Sign Up or Invest in CRNX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Crinetics Pharmaceuticals Inc shares

What is Crinetics Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Crinetics Pharmaceuticals Inc (CRNX) is $57.99. The 52-week low price of Crinetics Pharmaceuticals Inc (CRNX) is $24.1.

What is Crinetics Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Crinetics Pharmaceuticals Inc (CRNX) is

What is Crinetics Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Crinetics Pharmaceuticals Inc (CRNX) is 4.55

What is Crinetics Pharmaceuticals Inc dividend yield?

The dividend yield of Crinetics Pharmaceuticals Inc (CRNX) is 0.00%

What is the Market Cap of Crinetics Pharmaceuticals Inc?

The market capitalization of Crinetics Pharmaceuticals Inc (CRNX) is $4.88B

What is Crinetics Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Crinetics Pharmaceuticals Inc is CRNX

How Can Investors Use Crinetics Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Crinetics Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Crinetics Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Crinetics Pharmaceuticals Inc shares for Indian investors?

When investing in Crinetics Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Crinetics Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Crinetics Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Crinetics Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Crinetics Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Crinetics Pharmaceuticals Inc Share Price

Crinetics Pharmaceuticals Inc Analyst Forecast

Crinetics Pharmaceuticals Inc Share Price Chart

Crinetics Pharmaceuticals Inc Key Stock Metrics

About Crinetics Pharmaceuticals Inc, Common Stock

Crinetics Pharmaceuticals Inc Stock Returns

Crinetics Pharmaceuticals Inc Financials

Crinetics Pharmaceuticals Inc Ratios

Crinetics Pharmaceuticals Inc Liquidity Ratios

Crinetics Pharmaceuticals Inc Asset Efficiency Ratios

Crinetics Pharmaceuticals Inc Liability Ratios

Crinetics Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Crinetics Pharmaceuticals Inc Share Price

Crinetics Pharmaceuticals Inc Analyst Forecast

Crinetics Pharmaceuticals Inc Share Price Chart

Crinetics Pharmaceuticals Inc Key Stock Metrics

About Crinetics Pharmaceuticals Inc, Common Stock

Crinetics Pharmaceuticals Inc Stock Returns

Crinetics Pharmaceuticals Inc Financials

Crinetics Pharmaceuticals Inc Ratios

Crinetics Pharmaceuticals Inc Liquidity Ratios

Crinetics Pharmaceuticals Inc Asset Efficiency Ratios

Crinetics Pharmaceuticals Inc Liability Ratios

Crinetics Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²